Background: Epoxyeicosatrienoic acids (EETs) are cytochrome P450 metabolites of
INTREODUCTION
Hypercholesterolemia has emerged as a strong risk The present study aimed to investigate the possible beneficial effects of AUDA on the plasma lipid profile and on vascular function of hypercholesterolemic rats.
Materials and Methods

Laboratory animals
Forty five healthy male albino rats (100±20 g), ageing from 6-7 weeks were kept in the 
Study design:
A group of 15 rats were fed on standard rat chow throughout the study and served as controls. While Hypercholesterolemic (HC) rats were randomly divided into two groups (15 rats each): AUDAtreated HC rats; this group was given AUDA (Sigma-Aldrich) (0.35 mg/ kg), by oral gavage every other day for 10 weeks (6). Untreated HC group received distilled water through gavage every other day for 10 weeks. Type VI (complicated) lesion: surface defects, hematoma, hemorrhage, and thrombus.
Immunohistochemistry for e-Nos
The deparaffinized aortic tissue sections were rehydrated in graded alcohols.
Immunohistochemical staining was performed using an avidin-biotinylated immunoperoxidase method and according to the manufacture protocol.
The endogenous peroxidase activity was quenched with 3% hydrogen peroxide for 10 min. for multiple comparisons and p-value ≤ 0.05 was defined to be statistically significant.
Results
Serum lipid profile after 8 weeks (post diet)
In this study, the effect of diet was assessed after 8 weeks to prove hypercholesterolemia according to lipid profile changes before and after diet. Our results showed significant increase in Total-C with mean value of 111.48±21.01 mg/dl as compared to the control group 87.26±16.58 mg/dl (P=0.0013).
Also, there was a marked increase in TG with mean value of 102.22±45.47 mg/dl as compared to control with a mean 80.70±13.61 mg/dl (P=0.023).
In addition there was a marked reduction of the protective HDL-C in high cholesterol fed rats versus the control group (P=0.049). Moreover, the increase in LDL-C and non HDL-C was highly significant in comparison with the control group (p=0.000007 and P=0.000001), respectively (figure 1).
Serum lipid profile after 10 weeks of treatment:
Ten weeks oral treatment with AUDA, produced a significant decrease in Total-C as compared to untreated HC rats (P<0.001).However, Total-C was still significantly higher than control rats (P < 0.05). TG level also was significantly elevated in untreated HC rats (P<0.05) while in AUDA treated rats there was no statistically significant difference versus control group (P=0.495). Meanwhile, there was highly significant difference between AUDA treated and untreated groups (P<0.001).
HDL was significantly higher in AUDA treated group than control group (P < 0.001) and untreated HC group (P < 0.05). AUDA treated group showed a significant decrease of LDL in comparison to the untreated group (P < 0.05). However, there was no significant difference between AUDA treated group and control group (P = 0.625). As regards non HDL-C, AUDA treated group showed significant decrease in non HDL-C in relation to untreated HC group (P < 0.05).There was no significant difference between control group and AUDA treated group (P=0.169) but the difference between control group and the untreated group was highly significant (P < 0.001) (figure 2). 
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Discussion
In the current work, HC was successfully induced 
Conclusions:
We can conclude that AUDA treatment causes protection against EET degradation potentiating its beneficial functions regarding improving lipid profile and protect against development of atherosclerotic histopathological changes. AUDA also has improved endothelial function, vasodilatory response and vascular reactivity.
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